Chargement en cours...
Treatment of unresectable cutaneous squamous cell carcinoma with pembrolizumab
Currently, there are few effective therapies for locally advanced and metastatic cutaneous squamous cell carcinoma (cSCC); however, there is recent evidence supporting the use of immunological therapies in cSCC given the typically high mutation burden and association with immunosuppressed states. Th...
Enregistré dans:
| Publié dans: | BMJ Case Rep |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6685369/ https://ncbi.nlm.nih.gov/pubmed/31377718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-229915 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|